A modest protocol.
D000678:Amygdalin / Q000627:therapeutic use*; D001291:Attitude of Health Personnel; D002986:Clinical Trials as Topic / Q000592:standards*; D004311:Double-Blind Method; D004341:Drug Evaluation; D004992:Ethics, Medical; D006077:Government Agencies; D006801:Humans; D007258:Informed Consent; D009369:Neoplasms / Q000628:therapy; D010820:Physicians / Q000706:statistics & numerical data; D012107:Research Design; D018570:Risk Assessment; D014481:United States
D000678:Amygdalin